Pharma investors mobilise on reputational risk concerns

The opioid crisis warns of a need to look beyond drug companies’ sales volumes
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals